CIMPRESS plc incurred revolving credit of $250 million senior secured revolving credit facility with JPMorgan Chase Bank, N.A. at SOFR (with a SOFR floor of 0.00%) plus 2.25% to 3.00%, depending on the Company’ maturing June 4, 2031.
“as provided in the Restated Credit Agreement. The New Term Loan B bears interest at SOFR (with a SOFR floor of 0.00%) plus 2.50% and was issued at 99.75% of par; and ◦ a $250 million senior secured revolving credit facility with a maturity date of June 4, 2031 (the “Revolving Credit Facility”). U.S. dollar-denominated SOFR-based borrowings under the Revolving”
Debt Financings
CIMPRESS plc incurred term loan of $1.1 billion senior secured Term Loan B with JPMorgan Chase Bank, N.A. at SOFR (with a SOFR floor of 0.00%) plus 2.50% maturing June 4, 2033.
“Bank, N.A., as administrative agent (as amended and restated as of June 4, 2026, the “Restated Credit Agreement”). The Restated Credit Agreement consists of the following: ◦ a $1.1 billion senior secured Term Loan B with a maturity date of June 4, 2033 (the “New Term Loan B”), subject to a springing maturity date that is 91 days prior to the maturity date of the”
Material Agreements
CIMPRESS plc amended Amendment and Restatement Agreement with JPMorgan Chase Bank, N.A. and J.P. Morgan SE, as administrative agents, and the lenders named therein valued at $1.1 billion (effective 2026-06-04).
“On June 4, 2026, Cimpress plc (the "Company") entered into an Amendment and Restatement Agreement (the "Amendment and Restatement Agreement") among the Company and five of its subsidiaries, Vistaprint Limited, Cimpress Schweiz GmbH, Vistaprint B.V., Vistaprint Netherlands B.V., and Cimpress USA Incorporated, as borrowers (collectively, the “Borrowers”); the lenders named therein, as lenders; and JPMorgan Chase Bank, N.A. and J.P. Morgan SE, as administrative agents for the lenders.”
Earnings Releases
CIMPRESS plc reported financial results for the fiscal quarter ended March 31, 2026.
“On April 29, 2026, Cimpress plc posted on its web site its Q3 Fiscal Year 2026 Quarterly Earnings Document announcing and discussing its financial results for the fiscal quarter ended March 31, 2026.”
Wayne Ting was appointed as Director at CIMPRESS plc.
“On May 27, 2025, the Board of Directors of Cimpress plc (the “Company”) appointed Wayne Ting to the Board to serve for a term of approximately two and a half years ending at the conclusion of the Company’s annual general meeting of shareholders in 2027.”
Debt Financings
CIMPRESS plc amended credit facility with JPMorgan Chase Bank N.A. at SOFR plus 3.00% maturing May 17, 2028.
“Amendment 2 reduced the interest rate margin of the USD Tranche by 50 basis points, from SOFR plus 3.50% to SOFR plus 3.00%”
Material Agreements
CIMPRESS plc amended Amendment No. 2 with JPMorgan Chase Bank N.A., as administrative agent for the lenders (effective 2024-05-15).
“On May 15, 2024, Cimpress plc (“Cimpress”) entered into Amendment No. 2 among Cimpress and five of its subsidiaries, Vistaprint Limited, Cimpress Schweiz GmbH, Vistaprint B.V., Vistaprint Netherlands B.V., and Cimpress USA Incorporated, as borrowers (collectively, the “Borrowers”); Cimpress' subsidiaries that guaranty the Borrowers' obligations; the financial institutions listed on the signature pages thereof; and JPMorgan Chase Bank N.A., as administrative agent for the lenders (the “Administrative Agent”) (“Amendment 2”), which amends the senior secured Credit Agreement dated as of October 21, 2011, as amended and restated as of February 8, 2013, as further amended and restated as of July 13, 2017, as further amended and restated as of May 17, 2021, and as previously amended among the Borrowers, the lenders named therein as lenders, and the Administrative Agent (the "Credit Agreement").”
“Cimpress delivered strong financial results in our third quarter, driven by a combination of revenue growth, gross margin expansion, and year-over-year operating expense efficiencies, and our outlook remains positive.”
Earnings Releases
CIMPRESS plc reported Q2 FY2024 results: revenue 9% on a reported basis and 6% on an organic constant-currency basis. Guidance raised.
“Consolidated revenue grew 9% on a reported basis and 6% on an organic constant-currency basis.”
Shareholder Votes
CIMPRESS plc shareholders approved Reappoint Sophie S. Gasperment to our Board of Directors at the 2023-12-14 meeting.
“Proposal Votes FOR Votes AGAINST Abstentions Broker Non-Votes 1. Reappoint Sophie S. Gasperment to our Board of Directors 17,739,252 4,485,255 8,243 3,042,053”
Earnings Releases
CIMPRESS plc reported financial results for Q1 fiscal year 2024 (fiscal quarter ended September 30, 2023).
“On October 25, 2023, Cimpress plc posted on its web site its Q1 Fiscal Year 2024 Quarterly Earnings Document announcing and discussing its financial results for the fiscal quarter ended September 30, 2023. The full text of the earnings document is furnished as Exhibit 99.1 to this report.”
Earnings Releases
CIMPRESS plc updated its FY2024 (fiscal year ending June 30, 2024) guidance (initiated).
“We expect consolidated FY2024 reported revenue growth (assuming recent currency rates) of at least 8%, and organic constant-currency revenue growth of at least 6%, lower than the growth in FY2023 since we have passed the anniversary of nearly all pricing increases designed to offset input cost inflation.”
Earnings Releases
CIMPRESS plc reported financial results for Q4 FY2023 (quarter ended June 30, 2023).
“Cimpress closed FY2023 with a strong fourth quarter, in which consolidated revenue grew 9% on both reported and organic constant-currency bases.”
Earnings Releases
CIMPRESS plc reported financial results for the fiscal quarter ended March 31, 2023.
“On April 26, 2023, Cimpress plc posted on its web site its Q3 Fiscal Year 2023 Quarterly Earnings Document announcing and discussing its financial results for the fiscal quarter ended March 31, 2023.”
Restructurings & Charges
CIMPRESS plc announced a restructuring with charges of approximately $25 million to $27 million affecting Vista business and Cimpress central teams (approximately 500 team members).
“these plans to generate about $100 million in annualized pre-tax cost savings. Cimpress estimates it will incur an aggregate pre-tax restructuring charge of approximately $25 million to $27 million, which includes $22 million to $24 million of severance-related expense and approximately $3 million of other restructuring charges. Of the total estimated”
Earnings Releases
CIMPRESS plc reported financial results for the fiscal quarter ended December 31, 2022.
“On January 25, 2023, Cimpress plc posted on its web site its Q2 Fiscal Year 2023 Quarterly Earnings Document announcing and discussing its financial results for the fiscal quarter ended December 31, 2022.”
Shareholder Votes
CIMPRESS plc shareholders approved Authorize Board of Directors or Audit Committee to determine remuneration of PricewaterhouseCoopers Ireland at the 2022-11-16 meeting.
“6. Authorize Board of Directors or Audit Committee to determine remuneration of PricewaterhouseCoopers Ireland 24,822,251 8,815 3,390 0”
Shareholder Votes
CIMPRESS plc shareholders approved Reappoint PricewaterhouseCoopers Ireland at the 2022-11-16 meeting.
CIMPRESS plc shareholders approved Reappoint Scott J. Vassalluzzo to our Board of Directors at the 2022-11-16 meeting.
“2. Reappoint Scott J. Vassalluzzo to our Board of Directors 18,936,546 4,692,108 7,459 1,198,343”
Shareholder Votes
CIMPRESS plc shareholders approved Reappoint Robert S. Keane to our Board of Directors at the 2022-11-16 meeting.
“1. Reappoint Robert S. Keane to our Board of Directors 23,517,307 115,908 2,898 1,198,343”
Dessislava Temperley was appointed as Director at CIMPRESS plc.
“On September 15, 2021, the Board of Directors of Cimpress plc appointed Dessislava Temperley to the Board to serve for a term of three years ending at the conclusion of Cimpress' annual general meeting of shareholders in 2024.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.